(PTGX) Protagonist - Performance 46.6% in 12m
PTGX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
51.31%
#9 in Peer-Group
Rel. Strength
82.25%
#1319 in Stock-Universe
Total Return 12m
46.55%
#26 in Peer-Group
Total Return 5y
180.68%
#6 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 70.9 |
| P/E Forward | 26.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 59.76 USD |
| 52 Week Low | 33.72 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 21.40 |
| Buy/Sell Signal +-5 | -2.53 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PTGX (46.6%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PTGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PTGX
| Total Return (including Dividends) | PTGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 1.08% | 4.38% | 4.99% |
| 3 Months | 5.17% | 5.22% | 10.23% |
| 12 Months | 46.55% | -7.16% | 14.42% |
| 5 Years | 180.68% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | PTGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -12.9% | 3.5% | 79.1% |
| 3 Months | 74.2% | 75.7% | 95.5% |
| 12 Months | 47% | -85.1% | 44.7% |
| 5 Years | 36.5% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th55.50 | -3.16% | -3.73% |
| 3 Month | %th52.50 | -0.05% | -4.60% |
| 12 Month | %th88.00 | 57.85% | 28.07% |
| 5 Years | %th97.50 | 272.30% | 33.54% |
FAQs
Does Protagonist (PTGX) outperform the market?
Yes,
over the last 12 months PTGX made 46.55%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months PTGX made 5.17%, while XBI made 5.22%.
Performance Comparison PTGX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PTGX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9.1% | -3.9% | 23.3% | 32% |
| US NASDAQ 100 | QQQ | -8.7% | -4.3% | 21.8% | 33% |
| German DAX 40 | DAX | -8.1% | 1.6% | 11.7% | 16% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.4% | -3.1% | 22.8% | 29% |
| Hongkong Hang Seng | HSI | -7.1% | -6% | 4.8% | 10% |
| India NIFTY 50 | INDA | -8% | -0.9% | 25.9% | 47% |
| Brasil Bovespa | EWZ | -11.8% | -6.9% | 0.4% | 33% |
PTGX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9% | -4.6% | 19% | 20% |
| Consumer Discretionary | XLY | -10.2% | -1.8% | 30.2% | 28% |
| Consumer Staples | XLP | -9.4% | 1.2% | 23.9% | 36% |
| Energy | XLE | -9.7% | -5% | 28.1% | 48% |
| Financial | XLF | -9.2% | -2.5% | 20.1% | 18% |
| Health Care | XLV | -8% | -1.4% | 30.8% | 51% |
| Industrial | XLI | -9.9% | -3.1% | 16.5% | 23% |
| Materials | XLB | -12.2% | -4.7% | 19.1% | 40% |
| Real Estate | XLRE | -8.2% | 0.2% | 24.7% | 34% |
| Technology | XLK | -8.6% | -8% | 20.3% | 35% |
| Utilities | XLU | -7.8% | 1.6% | 22% | 24% |
| Aerospace & Defense | XAR | -9.3% | -6.5% | 5% | -2% |
| Biotech | XBI | -8.7% | -3.3% | 37.4% | 54% |
| Homebuilder | XHB | -14% | -10.5% | 29.3% | 40% |
| Retail | XRT | -11.7% | -4.4% | 28.5% | 36% |
PTGX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -10% | -7.60% | 31.8% | 53% |
| Natural Gas | UNG | -4.2% | 9.7% | 39.4% | 53% |
| Gold | GLD | -7.6% | 1.9% | 4% | 3% |
| Silver | SLV | -7.6% | -4.1% | 6.6% | 23% |
| Copper | CPER | -11.4% | -5.1% | 2.7% | 29% |
PTGX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -7.3% | -2.2% | 27.9% | 46% |
| iShares High Yield Corp. Bond | HYG | -7.6% | -0.8% | 25.2% | 36% |